TCGX - Latest News and Investment Deals
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeTCGX
TCGX logo

TCGX

0 followers

About TCGX

TCG Crossover is a science-driven investment firm focused on advancing disruptive medicines. The firm operates in the life sciences investment space, funding and guiding early- to late-stage pharmaceutical and biotech ventures with a mission to accelerate breakthrough therapies. Based on the information available, it emphasizes scientific rigor and portfolio development in the biopharma sector, and positions itself as a dedicated investor in breakthrough medicines. The organization is associated with its online presence and professional network, including a LinkedIn profile.

Recent News

Recent Deals

Key Facts

HQ Location

Palo Alto, United States

Founded

2020

Employees

11 - 50

Status

Investor

Investor Type

Venture Investor

Website

https://tcgcrossover.com